Dear Customers
It is our great pleasure to invite you to visit our both No 93 during 32-nd Annual Congress of European Association of Nuclear Medicine (EANM).
The congress will take place on 12-16 October 2019 in Barcelona.
News
Dear Customers,
We kindly inform you that medicinal product Sr-89 chloride is again available, in accordance with the production schedule presenting at our website.
Waiting for your orders
NOTICE – the changes in the production schedule of Lu-177 chloride LutaPol
POLATOM...
New Technique to Fight Prostate Cancer: IAEA organizes first-of-a-kind training for Radiopharmacists
For the first time, radiopharmacists from across Central and Eastern Europe learned about an emerging technique in treating prostate cancer at an IAEA course organized at the National Centre for Nuclear Research in Poland last month....
Dear partners and friends - thank you for visiting our booth during 15-th Asia Pacific Conference for Non-Destructive Testing (November 13 – 17, 2017) in Singapore. It was pleasure to meet you and...
Thanks to our good relationships with our Ukrainian partner we have received really valuable for us copies of the certificates signed by Maria Sklodowska-Curie . The originals are at the Institute of the Academy of Sciences in Kharkov (ДЕРЖАВНА УСТАНОВА« ІНСТИТУТ МЕДИЧНОЇ РАДІОЛОГІЇ...
PROJEKTY WSPÓŁFINANSOWANE ZE ŹRÓDEŁ ZEWNĘTRZNYCH
Gallery
Polatom - Foto - Galeria
Polatom - Foto - Galeria
Polatom - Foto - Galeria
Polatom - Foto - Galeria
EANM 2016 Barcelona
E-handel
Products
Our product range includes radiopharmaceuticals, radiochemicals, radioactivity standards and sealed radiation sources. We offer a broad selection of services and workshops, and training.
About Us
National Centre for Nuclear Research, Radioisotope Centre POLATOM is manufacturer and distributor of the isotopic goods applied in medicine, research and development, industry and environment protection.
Certificates
The high professionalism of our company has been confirmed by a number of certificates including GMP for radiopharmaceutical production.